6-methyladenine has been researched along with Bladder Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, R; Yan, H; Zhang, L | 1 |
1 other study(ies) available for 6-methyladenine and Bladder Cancer
| Article | Year |
|---|---|
Identification of m6A suppressor EIF4A3 as a novel cancer prognostic and immunotherapy biomarker through bladder cancer clinical data validation and pan-cancer analysis.
Topics: Adenine; Biomarkers; Data Mining; DEAD-box RNA Helicases; Eukaryotic Initiation Factor-4A; Humans; Immunotherapy; Prognosis; Urinary Bladder Neoplasms | 2023 |